Showing results (21-30 of 357) with videos related to

Sort By:
Pageof 36
BMJ Clinical Evidence|May 20, 2009
End stage renal diseaseYoshio N Hall, Glenn M Chertow
Kidney International|August 28, 2009
Hemodialysis access failure: a call to action--revisitedRaymond M Hakim, Jonathan Himmelfarb
Seminars in Dialysis|October 6, 2004
Antioxidant therapy in uremia: evidence-based medicine?Carrie A Gordon, Jonathan Himmelfarb
Handbook of Experimental Pharmacology|December 19, 2009
Mechanisms of drug-induced nephrotoxicityThomas D Nolin, Jonathan Himmelfarb
Seminars in Nephrology|September 16, 2009
Creating research infrastructure and functionality to address chronic kidney disease: the Kidney Research InstituteJonathan Himmelfarb, Stuart J Shankland
Annual Review of Medicine|January 16, 2007
End-stage renal disease measures of qualityJonathan Himmelfarb, Alan S Kliger
Pediatric Nephrology (Berlin, Germany)|May 8, 2009
Tipping the redox balance of oxidative stress in fibrogenic pathways in chronic kidney diseaseDaryl M Okamura, Jonathan Himmelfarb
Current Opinion in Nephrology and Hypertension|October 18, 2003
Oxidative stress in uremiaJonathan Himmelfarb, Raymond M Hakim
Oxidative Medicine and Cellular Longevity|October 2, 2009
Primary mouse renal tubular epithelial cells have variable injury tolerance to ischemic and chemical mediators of oxidative stressAnne C Breggia, Jonathan Himmelfarb
Clinical Journal of the American Society of Nephrology : CJASN|January 8, 2024
From Home to Wearable Hemodialysis: Barriers, Progress, and OpportunitiesMatthew B Rivara, Jonathan Himmelfarb
Pageof 36